Use of Anti-Inflammatory Drugs and Lower Esophageal Sphincter–Relaxing Drugs and Risk of Esophageal and Gastric Cancers
- 31 October 2007
- journal article
- research article
- Published by Elsevier BV in Clinical Gastroenterology and Hepatology
- Vol. 5 (10), 1154-1159.e3
- https://doi.org/10.1016/j.cgh.2007.05.022
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeuticsPharmacoepidemiology and Drug Safety, 2006
- Randomized, Placebo-Controlled, Esophageal Squamous Cell Cancer Chemoprevention Trial of Selenomethionine and CelecoxibGastroenterology, 2005
- Intratracheal budesonide-poly (lactide-co-glycolide) microparticles reduce oxidative stress, VEGF expression, and vascular leakage in a benzo(a)pyrene-fed mouse modelJournal of Pharmacy and Pharmacology, 2005
- Hereditary colorectal cancer syndromesCancer Causes & Control, 2005
- Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control studyCancer Causes & Control, 2005
- Nonsteroidal Anti-inflammatory Drugs and Risk of Esophageal and Gastric CancerCancer Epidemiology, Biomarkers & Prevention, 2005
- Esophageal CancerThe New England Journal of Medicine, 2003
- Protective association of aspirin/NSAIDs and esophageal cancer: A systematic review and meta-analysisGastroenterology, 2003
- Rising incidence rate of esophageal adenocarcinoma and use of pharmaceutical agents that relax the lower esophageal sphincter (United States)Cancer Causes & Control, 1994
- Modern epidemiology?Journal of Epidemiology and Community Health, 1988